Characteristics of the participants. by Kazuhiro Suzuki (160528)

Subjects:

Maternal blood pH. by Pedro Henrique Salles Brito (10441343)

Subjects:

Maternal blood pO2. by Pedro Henrique Salles Brito (10441343)

Subjects:

Comparison of GHQ-12 total scores pre- and post- guideline change in the mask-wearing behavior. by Kazuhiro Suzuki (160528)

Subjects:

Elemental composition of Fly Ash. by Charles Sarala Rubi (21608723)

Subjects:

B–O Bond Reinforced Mechanical Stability of Alginate-Based Jammed Emulsion for Enhancing Pesticide Droplet Foliar Deposition by Yan Zhou (6523)

Subjects:

Composition of LM6 alloy. by Charles Sarala Rubi (21608723)

Subjects:

Image of the prepared sample (Pins and Disc). by Charles Sarala Rubi (21608723)

Subjects:

Impact of red blood cell-platelet ratio trajectories in the first four days before ICU admission on prognosis and clinical outcomes in the validation set. by Jie Zhao (49409)

Subjects:

Description of the study sites in the NRE. by Jeong-Soo Gim (18058588)

Subjects:

Micrograph of worn pin of LM6 alloy. by Charles Sarala Rubi (21608723)

Subjects:

Response graphs for GRG. by Charles Sarala Rubi (21608723)

Subjects:

B–O Bond Reinforced Mechanical Stability of Alginate-Based Jammed Emulsion for Enhancing Pesticide Droplet Foliar Deposition by Yan Zhou (6523)

Subjects:

Comparison of water quality parameters in the surface water before and after Nakdong River Estuary (NRE) opening. DO: dissolved oxygen; TN: total nitrogen; TP: total phosphorus. by Jeong-Soo Gim (18058588)

Subjects:

Clinical baseline data after PSM. by Jie Zhao (49409)

Subjects:

Impact of red blood cell-platelet ratio trajectories on prognosis and clinical outcomes in the first four days before ICU admission in the training set. by Jie Zhao (49409)

Subjects:

International Classification of Diseases Codes. by Jie Zhao (49409)

Subjects:

Characteristics of AEFIs with JEV-L vaccine in the pre-LAW and post-LAW period. by Chao Zhang (51048)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

Comparing demographic and clinical characteristics of patients before and COVID-19 outbreak. by Mahsa Motiei (18275525)

Subjects: